HealthScience and Research
Climb Bio reports 38% immunologic remission in kidney trial
Five of 13 patients reached immunologic remission at 12 weeks, while higher-dose cohorts and longer follow-up will guide development.
Canopy Growth Corporation shareholders authorize up to 1‑for‑15 reverse split
Directors retain discretion over the ratio for common and exchangeable shares, with no effective date set in the voting disclosure.
MiningCopper
Teck Resources reports reduced capacity at Highland Valley as strike begins
USW Local 7619 represents about 1,200 workers at the B.C. copper operation, whose production loss has not been quantified.
Analysis
Sterlite Technologies reports INR25.29B revenue and multiyear supply deals
A US$1.2 billion agreement spans 2026 to 2030, while a one-time tariff refund lifted the September quarter’s reported earnings.
Health
NASDAQ: GMABGenmab and Incyte agree to colorectal cancer combination trial
Genmab will conduct the Phase 1/2 study, while Incyte will co-fund it and supply its KRAS G12D inhibitor; a start date was not disclosed.
EnergyTechnology
Alphabet's Google expands Voltus virtual power plant agreement to 1 GW
Google will fund flexible household and business resources in PJM, but the companies disclose no price or delivery schedule.
HealthScience and Research
Pfizer details 25‑strain infant vaccine data as pivotal trials advance
A 401-infant presentation compared immune responses and safety with Prevnar 20; the company has not dated its pediatric Phase 3 readout.
Technology
NASDAQ: BTDRProprietary bitcoin holdings remained at zero as of Oct. 23, while the update omitted sale prices and cash proceeds.
Technology
NASDAQ: IPMThe California services acquisition would close in two stages, with cash, a seller note and an earnout subject to separate utility approvals.
Analysis
Finland grants Posiva nuclear waste disposal licence through 2070
Fortum's jointly owned disposal company must complete commissioning and pass a STUK inspection before operations can begin.
Latest
Atlas Energy Solutions closes US$424M bridge loan for data centre equipment
The delayed draw facility starts with US$171 million borrowed and a 180-day maturity, with an extension tied to supply agreements and lender consent.
Nokia reports €605M comparable operating profit and €1.5B in AI and cloud orders
The annual profit outlook is unchanged, while higher working capital needs and restructuring reduce expected cash conversion.
Invinity Energy Systems sets £25M equity raise at 10p a share
The National Wealth Fund is providing £12.2 million, with admission targeted for Nov. 12 subject to shareholder approval.
Gold Strike Resources reports 400m at 0.53 g/t gold at Florin
The first hole supports continuity within the resource footprint, but true widths remain unknown and assays from 10 holes are pending.
GSK wins FDA approval for Hibsago in chronic hepatitis B
The 24-week injection course targets eligible adults without cirrhosis, with boxed liver and platelet warnings.
Elevance Health raises 2026 profit outlook as revenue reaches US$50.4B
The benefit expense ratio improved to 90.6 per cent, but non-operating gains helped lift earnings and the annual forecast.
Mentioned this week
NASDAQCGCCanopy Growth Corporation
Canopy Growth Corporation shareholders authorize up to 1‑for‑15 reverse splitMining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
UraniumEnergy
Terra Innovatum shares 12 draft SOLO safety chapters with NRC
The reactor developer targets Oct. 30 for the remaining six chapters and retains its company-set 2027 deployment goal.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: DMACAn independent board will review ReMEDy2 in Q1 2027 and may resize the study to as many as 728 participants or stop it for futility.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
MiningGold
Canagold Resources drills 52.8 g/t gold over 4.64m at New Polaris
The interval also returned 0.83 per cent antimony, but true widths remain unknown after the completed 14-hole campaign.
Mining
CVE: WSpartan Metals expands Victorio measured and indicated resource by 9.5%
The estimate uses a higher value cutoff and revised metal prices ahead of a fourth-quarter economic study of the New Mexico project.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
NASDAQ: NNEAn initial study is estimated at six months; NANO disclosed no retainer amount, fabrication price or component delivery date.
Uranium
TSE: CCOConstruction is underway on a commercial LEU+ factory, with listed owners Cameco and Brookfield Renewable exposed through their Westinghouse interests.
Energy
CNSX: AIBZ.UInitial civil works are complete, but the issuer disclosed no contract price, funding commitment or construction timetable.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Psychedelics
CNSX: OPTIThe capsules are intended for three programs, including a Canadian Phase 3 PTSD trial of up to 100 people expected to begin in 2027.
Cannabis
TSE: OGIThe province estimates illegal retailers take 30 per cent of cannabis sales and proposes inspection, seizure and penalty powers for the AGCO.
Cannabis
TSE: CURAThe bid offers US$1 in cash plus 0.4013 Curaleaf shares for each Aurora share, with a Dec. 4 tender deadline.
Cannabis
TSE: CRONCash earnouts tied to 2026 and 2027 earnings add to the base price for a grower supplying nearly all 69 shops in the Dutch pilot.